Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Free PDFs:
Hepatology 2014 (5th Edition, 612 pages)
Short Guide to Hepatitis C (2014 Edition, 206 pages)

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 123 articles:
HTML format
Text format



Single Articles


    August 2014
  1. MAASOUMY B, Port K, Deterding K, Honer Zu Siederdissen C, et al
    Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.
    Eur J Gastroenterol Hepatol. 2014;26:836-45.
    PubMed     Text format     Related articles    Abstract available


    July 2014
  2. LAUFFENBURGER JC, Mayer CL, Hawke RL, Brouwer KL, et al
    Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  3. ZHANG ZY, Zhou ZQ, Zhou GW
    Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  4. OZARAS R, Mete B, Ceylan B, Ozgunes N, et al
    First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment.
    Eur J Gastroenterol Hepatol. 2014;26:774-80.
    PubMed     Text format     Related articles    Abstract available


  5. DI BISCEGLIE AM, Sulkowski M, Gane E, Jacobson IM, et al
    VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2014;26:761-73.
    PubMed     Text format     Related articles    Abstract available


    June 2014
  6. VEIGA Z, Pereira GH, Fernandes FF, Mariz DM, et al
    Reply to: Telaprevir-induced acute kidney injury during treatment of chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2014;26:687-8.
    PubMed     Text format     Related articles   


    April 2014
  7. SHAHID M, Idrees M, Nasir B, Raja AJ, et al
    Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  8. ATSUKAWA M, Tsubota A, Shimada N, Kondo C, et al
    Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  9. CEYLAN B, Aslan F, Yardimci C, Fincanci M, et al
    Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries.
    Eur J Gastroenterol Hepatol. 2014;26:493-4.
    PubMed     Text format     Related articles   


  10. PANAYI V, Froud OJ, Vine L, Laurent P, et al
    The natural history of autoimmune hepatitis presenting with jaundice.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


    March 2014
  11. AZIZ H, Gill U, Raza A, Gill ML, et al
    Metabolic syndrome is associated with poor treatment response to antiviral therapy in chronic hepatitis C genotype 3 patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  12. JERKEMAN A, Norkrans G, Lidman C, Westin J, et al
    Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  13. EFE C, Ozaslan E, Heurgue-Berlot A, Kav T, et al
    Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  14. ZHANG Q, Shang L, Zang Y, Chen X, et al
    alpha-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


    February 2014
  15. YANG X, Li J, Zhou L, Liu J, et al
    Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  16. CRAXI A, Piccinino F, Ciancio A, Iannacone C, et al
    Real-world outcomes in patients with chronic hepatitis C: primary results of the PROBE study.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


  17. CHU KJ, Lu CD, Dong H, Fu XH, et al
    Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Eur J Gastroenterol Hepatol. 2014;26:192-9.
    PubMed     Text format     Related articles    Abstract available


  18. GUNER R, Kocak Tufan Z
    Telaprevir use in a chronic hepatitis C patient with hemophilia.
    Eur J Gastroenterol Hepatol. 2014;26:248.
    PubMed     Text format     Related articles   


  19. MESSORI A, Fadda V, Maratea D, Trippoli S, et al
    Pegylated interferon-alpha2a versus pegylated interferon-alpha2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis.
    Eur J Gastroenterol Hepatol. 2014;26:246-8.
    PubMed     Text format     Related articles   


  20. CRISPO A, Barba M, Malvezzi M, Ciliberto G, et al
    Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data.
    Eur J Gastroenterol Hepatol. 2014;26:245-6.
    PubMed     Text format     Related articles   


  21. KIKUCHI H, Numao H
    Telaprevir-induced acute kidney injury during treatment of chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2014;26:244-5.
    PubMed     Text format     Related articles   


  22. AOUFI RABIH S, Alfaya Munoz LB, Fidalgo Broncano A, Villanueva Hernandez R, et al
    Should we investigate retinopathy in chronic hepatitis C patients receiving treatment with interferon?
    Eur J Gastroenterol Hepatol. 2014;26:242-3.
    PubMed     Text format     Related articles   


  23. CEYLAN B, Fincanci M, Yardimci C, Eren G, et al
    Mean platelet volume in chronic viral hepatitis.
    Eur J Gastroenterol Hepatol. 2014;26:240-1.
    PubMed     Text format     Related articles   


    January 2014
  24. RAMSOEKH D, Taimr P, Vanwolleghem T
    Reversible severe hepatitis in anorexia nervosa: a case report and overview.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


    December 2013
  25. FUJIWARA K , Yasui S, Yokosuka O
    Corticosteroid for severe acute exacerbation of chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013;25:1492.
    PubMed     Text format     Related articles   


    October 2013
  26. BUTT FA , Amin I, Idrees M, Iqbal M, et al
    Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


    September 2013
  27. KOFFI J , Egounlety R, Pradat P, Lebosse F, et al
    Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


    August 2013
  28. SAITO M , Seo Y, Yano Y, Momose K, et al
    Serum albumin and prothrombin time before entecavir treatment in chronic hepatitis B or cirrhosis are related to amelioration of liver function after treatment.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  29. AALOUANE R, Hafidi H, Rammouz I
    Bipolar disorder and interferon treatment: how to manage?
    Eur J Gastroenterol Hepatol. 2013;25:1002.
    PubMed     Text format     Related articles   


    July 2013
  30. SAGRINI E , Ardoino I, Marano G, Gianstefani A, et al
    Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


    June 2013
  31. NORTH CS , Devereaux R, Pollio DE, Hong BA, et al
    Patient perspectives on hepatitis C and its treatment.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  32. NIEDERAU C , Mauss S, Boker K, Lutz T, et al
    Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  33. WAQAR M , Khan AU, Rehman HU, Idrees M, et al
    Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan).
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  34. FABRIS P , Carlotto A, Bianco TD, Malfatti F, et al
    Therapy of chronic hepatitis C with PEG-IFN alpha-2b plus ribavirin in patients with genotype 2 or 3: 16 versus 24 weeks, clinical outcome and direct cost analyses.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  35. POTTS JR , Howard MR, Verma S
    Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes.
    Eur J Gastroenterol Hepatol. 2013;25:659-64.
    PubMed     Text format     Related articles    Abstract available


    May 2013
  36. GIORDANINO C , Sacco M, Ceretto S, Smedile A, et al
    Durability of the response to peginterferon-alpha2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  37. VIGANI AG , Tozzo R, Quezada A, Diaz AC, et al
    Chronic hepatitis C virus infection: it is not only about the liver.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  38. DOGAN UB , Akin MS, Yalaki S
    Sustained virological response based on the week 4 response in hepatitis C virus genotype 1 patients treated with peginterferons alpha-2a and alpha-2b, plus ribavirin.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  39. SOCKALINGAM S , Blank D, Banga CA, Mason K, et al
    A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  40. KELLY EM , Cooper CL
    Hepatitis C antiviral treatment outcomes are comparable between clinical trial participants and recipients of standard-of-care therapy: an analysis of trial effect.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  41. DONAGHY L , Barry FJ, Hunter JG, Stableforth W, et al
    Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  42. DOGAN UB , Golge N, Akin MS
    The comparison of the efficacy of pegylated interferon alpha-2a and alpha-2b in chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  43. BALTA S , Demirkol S, Akgul EO
    Mean platelet volume as a surrogate marker of inflammation in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles   


    April 2013
  44. EFE C , Heurgue-Berlot A, Ozaslan E, Purnak T, et al
    Late autoimmune hepatitis after hepatitis C therapy.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  45. ULLAH S , Rehman HU, Idrees M
    Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  46. LIU J , Yu W, Liu S
    Positive ratio of specific antibodies to F protein in serum samples from chronic HCV-infected patients using an enzyme-linked immunosorbent assay: systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  47. SUK KT , Kim HC, Namkung S, Han SH, et al
    Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  48. BRUNNER N , Senn O, Rosemann T, Falcato L, et al
    Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  49. HUANG Z , Deng H, Zhao Q, Zheng Y, et al
    Peginterferon-alpha2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  50. EL RAY A , Asselah T, Moucari R, El Ghannam M, et al
    Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2013;25:421-7.
    PubMed     Text format     Related articles    Abstract available


  51. ZENI LP , Viera PD, Michalczuk MT, Birkhan OA, et al
    Hepatitis C virus induces abnormalities in surface and intraocular pressure: a comparative study.
    Eur J Gastroenterol Hepatol. 2013;25:411-5.
    PubMed     Text format     Related articles    Abstract available


  52. AL-ASHGAR HI , Khan MQ, Helmy A, Al-Thawadi S, et al
    Relationship of interferon-gamma-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4.
    Eur J Gastroenterol Hepatol. 2013;25:404-10.
    PubMed     Text format     Related articles    Abstract available


    March 2013
  53. HE B , Zhang Y, Lu MH, Cao YL, et al
    Glucocorticoids can increase the survival rate of patients with severe viral hepatitis B: a meta-analysis.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  54. DOGAN UB , Atabay A, Akin MS, Yalaki S, et al
    The comparison of the efficacy of pegylated interferon alpha-2a and alpha-2b in chronic hepatitis C patients with genotype 1.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  55. HYDES T , Allen H, Al-Shamma S, Hovell C, et al
    District general hospital networks can provide safe and effective hepatitis C treatment: results of a 5-year audit.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  56. UCAR F , Sezer S, Ginis Z, Ozturk G, et al
    APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  57. CHEN L , Liu W, Lai S, Li Y, et al
    Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  58. KUMARI N , Kathuria R, Srivastav A, Krishnani N, et al
    Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children.
    Eur J Gastroenterol Hepatol. 2013;25:333-7.
    PubMed     Text format     Related articles    Abstract available


    February 2013
  59. ANSARI MA , Irshad M, Agarwal SK, Chosdol K, et al
    Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  60. SAAD Y , Ahmed A, Saleh DA, Doss W, et al
    Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  61. PAPADOPOULOS N , Manolakopoulos S, Deutsch M, Mela M, et al
    Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  62. MA Q , Qin B, Gong X, Lu X, et al
    Prediction of response to interferon alpha-1b in HBeAg-positive chronic hepatitis B: a clue from HBsAg levels.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  63. ZHANG Y , Lian JQ, Li Y, Wang JP, et al
    Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  64. PAPASTERGIOU V , Stampori M, Lisgos P, Pselas C, et al
    Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective stud
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


    January 2013
  65. MA J , Jiang Y, Gong G
    Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  66. CEYLAN B , Fincanci M, Yardimci C, Eren G, et al
    Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  67. DE VROEY B , Moreno C, Laleman W, van Gossum M, et al
    Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  68. LEE HK , Kim KA, Lee JS, Kim NH, et al
    Window period of anti-hepatitis A virus immunoglobulin M antibodies in diagnosing acute hepatitis A.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  69. KNOP V , Bergk A, Schlosser B, Thieringer J, et al
    Bezafibrate maintenance therapy in patients with advanced chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Related articles    Abstract available


  70. AKSOY EK , Yilmaz B, Koklu S
    Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome developed in a patient with vitiligo and Hashimoto thyroiditis.
    Eur J Gastroenterol Hepatol. 2013;25:121-2.
    PubMed     Text format     Related articles   


    December 2012
  71. MA P , Yang JM, Hou W, Song SD, et al
    A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  72. KANT J , Moller B, Heyne R, Herber A, et al
    Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  73. AKSU HS , Kurtaran B, Onlen Y, Namiduru M, et al
    Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
    Eur J Gastroenterol Hepatol. 2012;24:1393-1399.
    PubMed     Text format     Related articles    Abstract available


    November 2012
  74. LIU A , Ha NB, Lin B, Yip B, et al
    Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


    October 2012
  75. CARDOSO C , Alves AL, Augusto F, Freire R, et al
    Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  76. GULNAZ A , Sayyed AH, Amin F, Khan AU, et al
    Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  77. NAYAK NC , Jain D, Vasdev N, Gulwani H, et al
    Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants.
    Eur J Gastroenterol Hepatol. 2012;24:1199-208.
    PubMed     Text format     Related articles    Abstract available


    September 2012
  78. SOYKAN I , Yakut M, Keskin O
    Hepatitis C virus antibody positivity may not be associated with hepatitis C infection in patients with autoimmune gastritis.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles   


  79. EL-MEZAYEN HA , Toson ES, Shiha GE
    Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  80. LILEA GC , Streba CT, Vere CC, Rogoveanu I, et al
    Treatment with Peg-IFNalpha2a/ribavirin and low-dose NSAID for patients with chronic hepatitis C and rheumatoid syndrome.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  81. GHEORGHE L , Csiki IE, Iacob S, Gheorghe C, et al
    The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  82. SIMSEK H , Alp A, Yilmaz B, Balaban YH, et al
    The genotype frequencies of IL28B polymorphisms (rs12979860, rs8099917) among Turkish patients with hepatitis C.
    Eur J Gastroenterol Hepatol. 2012;24:1113-5.
    PubMed     Text format     Related articles   


    August 2012
  83. MUSIALIK J , Suchecka W, Klimacka-Nawrot E, Petelenz M, et al
    Taste and appetite disorders of chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  84. GUO Y , Zhang W, Zhang Y, Lin X, et al
    Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  85. VOICAN CS , Naveau S, Perlemuter G
    Successful antiviral therapy for hepatitis C virus-induced cirrhosis after an increase in the platelet count with romiplostim: two case reports.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  86. HARTLEB M , Gutkowski K, Zejda JE, Chudek J, et al
    Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey - PolSenior.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


    July 2012
  87. NEVENS F , Colle I, Michielsen P, Robaeys G, et al
    Resource use and cost of hepatitis C-related care.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  88. KARABAY O , Tuna N, Esen S
    Comparative efficacy of pegylated interferons alpha-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  89. DABROWSKA MM , Mikula T, Wiercinska-Drapalo A
    HCV coinfection possibly promotes left ventricular dysfunction development: analysis of brain natriuretic peptide serum levels in HCV/HIV-coinfected and HIV-monoinfected patients.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  90. GRADY BP , Vanhommerig JW, Schinkel J, Weegink CJ, et al
    Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  91. CHATZIDAKI V , Choumerianou D, Dimitriou H, Kouroumalis E, et al
    Genetic variants associated with susceptibility to mother-to-child transmission of hepatitis B virus.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


    June 2012
  92. SINGAL AK , Kuo YF, Anand BS
    Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  93. RIJCKBORST V , Ferenci P, Akdogan M, Pinarbasi B, et al
    Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon alpha-2a: progressive decrease in hepatitis B surface antigen in responders.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


    May 2012
  94. CHIN JL , Nicholas RM, Russell J, Carr M, et al
    Spontaneous clearance of hepatitis C infection after liver transplantation from IL28B rs12979860 CC donors.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  95. DACOSTA DIBONAVENTURA M , Yuan Y, Wagner JS, L'italien GJ, et al
    The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  96. KARATAPANIS S , Skorda L, Marinopoulos S, Papastergiou V, et al
    Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  97. ESKESEN AN , Melum E, Moghaddam A, Bjoro K, et al
    Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  98. NING LH , Hao J, Liao ZL, Zhou YY, et al
    A survey on the current trends in the management of hepatitis B in China.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  99. KARCHAVA M , Sharvadze L, Chkhartishvili N, Nelson K, et al
    IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  100. EFE C , Wahlin S, Ozaslan E, Berlot AH, et al
    Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.
    Eur J Gastroenterol Hepatol. 2012;24:531-4.
    PubMed     Text format     Related articles    Abstract available


  101. ZENG QA , Qiu J, Hong J, Li Y, et al
    Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosis.
    Eur J Gastroenterol Hepatol. 2012;24:575-82.
    PubMed     Text format     Related articles    Abstract available


    April 2012
  102. DELLA CORTE C , Sartorelli MR, Sindoni CD, Girolami E, et al
    Autoimmune hepatitis in children: an overview of the disease focusing on current therapies.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  103. KELLY EM , Corace K, Emery J, Cooper CL, et al
    Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  104. ABBAS E , Shaker O, Abd El Aziz G, Ramadan H, et al
    Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Eur J Gastroenterol Hepatol. 2012;24:458-63.
    PubMed     Text format     Related articles    Abstract available


    March 2012
  105. INNES HA , Hutchinson SJ, Allen S, Bhattacharyya D, et al
    Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


    February 2012
  106. BUTI M , Morillas RM, Prietoj M, Diago M, et al
    Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  107. TANWAR S , Wright M, Foster GR, Ryder SD, et al
    Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon alpha-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  108. MOHAMED AF , Johnson FR, Hauber AB, Lescrauwaet B, et al
    Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


    January 2012
  109. FLOREANI A , Antoniazzi S, Mescoli C, Bergasa NV, et al
    Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  110. WU DL , Xu GH, Lu SM, Ma BL, et al
    Age versus clinical virological characteristics in chronic hepatitis B virus infection: a case series study in China.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  111. ARAI M , Togo S, Kanda T, Fujiwara K, et al
    Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


  112. WELTE S , Gagesch M, Weber A, Longerich T, et al
    Fulminant liver failure in Wilson's disease with histologic features of postinfantile giant cell hepatitis; cytomegalovirus as the trigger for both?
    Eur J Gastroenterol Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available


    December 2011
  113. GOSWAMI RP , Goswami RP, Ray Y, Rahman M, et al
    Absolute CD4 counts in monoinfected chronic hepatitis B patients in the advanced immune-active stage.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles   


    November 2011
  114. LIN YM , Sheu MJ, Kuo HT, Feng IC, et al
    The early on-treatment perihepatic lymph node response predicts sustained viral response of anti-hepatitis C virus therapy.
    Eur J Gastroenterol Hepatol. 2011;23:990-6.
    PubMed     Text format     Related articles    Abstract available


  115. BUGDACI MS , Sokmen M, Toptas T
    Additive effect of folic acid deficiency on pegylated interferon's bone marrow toxicity.
    Eur J Gastroenterol Hepatol. 2011;23:1079-80.
    PubMed     Text format     Related articles   


  116. HUISMAN EJ , Trip EJ, Siersema PD, van Hoek B, et al
    Protein energy malnutrition predicts complications in liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2011;23:982-9.
    PubMed     Text format     Related articles    Abstract available


  117. BOURSIER J , Chaigneau J, Roullier V, Laine F, et al
    Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
    Eur J Gastroenterol Hepatol. 2011;23:974-81.
    PubMed     Text format     Related articles    Abstract available


    October 2011
  118. SARTORI M , Andorno S, Rossini A, Boldorini R, et al
    A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available


  119. FLISIAK R , Halota W, Horban A, Juszczyk J, et al
    Prevalence and risk factors of HCV infection in Poland.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available


  120. YU JW , Sun LJ, Zhao YH, Kang P, et al
    The study of relationship between neutropenia and infection during treatment with peginterferon alpha and ribavirin for chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available


  121. AMER ME , El-Sayed SZ, El-Kheir WA, Gabr H, et al
    Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.
    Eur J Gastroenterol Hepatol. 2011;23:936-41.
    PubMed     Text format     Related articles    Abstract available


    September 2011
  122. TAFAREL JR , Tolentino LH, Correa LM, Bonilha DR, et al
    Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers.
    Eur J Gastroenterol Hepatol. 2011;23:754-8.
    PubMed     Text format     Related articles    Abstract available


    July 2011
  123. KUMAR M , Kamani L, Hussain R, Siddique S, et al
    Successful pregnancy outcome in decompensated chronic liver disease with portal vein thrombosis: case report and review of literature.
    Eur J Gastroenterol Hepatol. 2011;23:617-9.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: